BIONIK LABORATORIES CORP.: 10-Q filed 2017-11-13
What BIONIK LABORATORIES CORP. reported in its quarterly report filed 2017-11-13 (fiscal Q2 2018): 41 published measures, 113 facts as tagged in accession 0001144204-17-058368.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2017-11-13
- Fiscal period
- fiscal Q2 2018
- Accession
- 0001144204-17-058368 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BIONIK LABORATORIES CORP. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 27,958,630 | USD | |
| At 2017-03-31 | 28,968,900 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-03-31 | 4,818,205 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 20,873,148 | USD | |
| At 2017-03-31 | 24,150,695 | USD | |
| At 2016-03-31 | 5,399,896 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 136,080 | USD | |
| At 2017-03-31 | 543,650 | USD | |
| At 2016-09-30 | 1,677,310 | USD | |
| At 2016-03-31 | 5,381,757 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-09-30 | -5,855,877 | USD | 183 |
| 2016-04-01 to 2017-03-31 | -8,069,402 | USD | 365 |
| 2016-04-01 to 2016-09-30 | -3,332,273 | USD | 183 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-09-30 | -3,059,849 | USD | 183 |
| 2016-04-01 to 2016-09-30 | -3,964,234 | USD | 183 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-09-30 | 2,669,461 | USD | 183 |
| 2016-04-01 to 2016-09-30 | 266,635 | USD | 183 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-09-30 | -17,182 | USD | 183 |
| 2016-04-01 to 2016-09-30 | -6,848 | USD | 183 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | -26,973,321 | USD | |
| At 2017-03-31 | -21,076,419 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 101,794,615 | shares | 92 |
| 2017-04-01 to 2017-09-30 | 99,335,514 | shares | 183 |
| 2016-07-01 to 2016-09-30 | 85,924,462 | shares | 92 |
| 2016-04-01 to 2016-09-30 | 87,232,426 | shares | 183 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 101,794,615 | shares | 92 |
| 2017-04-01 to 2017-09-30 | 99,335,514 | shares | 183 |
| 2016-07-01 to 2016-09-30 | 85,924,462 | shares | 92 |
| 2016-04-01 to 2016-09-30 | 87,232,426 | shares | 183 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | -0.04 | USD/shares | 92 |
| 2017-04-01 to 2017-09-30 | -0.06 | USD/shares | 183 |
| 2016-07-01 to 2016-09-30 | -0.02 | USD/shares | 92 |
| 2016-04-01 to 2016-09-30 | -0.04 | USD/shares | 183 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | -0.04 | USD/shares | 92 |
| 2017-04-01 to 2017-09-30 | -0.06 | USD/shares | 183 |
| 2016-07-01 to 2016-09-30 | -0.02 | USD/shares | 92 |
| 2016-04-01 to 2016-09-30 | -0.04 | USD/shares | 183 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 196,231 | USD | |
| At 2017-03-31 | 227,421 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 762,208 | USD | 92 |
| 2017-04-01 to 2017-09-30 | 1,013,256 | USD | 183 |
| 2016-07-01 to 2016-09-30 | 204,842 | USD | 92 |
| 2016-04-01 to 2016-09-30 | 424,090 | USD | 183 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 593,434 | USD | |
| At 2017-03-31 | 1,402,580 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-09-30 | 234,463 | USD | 183 |
| 2016-04-01 to 2016-09-30 | 10,031 | USD | 183 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 7,085,482 | USD | |
| At 2017-03-31 | 4,818,205 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 957,360 | USD | |
| At 2017-03-31 | 784,726 | USD |
Goodwill carrying amount
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 22,308,275 | USD | |
| At 2017-03-31 | 22,308,275 | USD | |
| At 2016-04-21 | 22,308,275 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 37,196 | USD | |
| At 2017-03-31 | 383,903 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 3,593,308 | USD | 92 |
| 2017-04-01 to 2017-09-30 | 5,720,895 | USD | 183 |
| 2016-07-01 to 2016-09-30 | 1,807,323 | USD | 92 |
| 2016-04-01 to 2016-09-30 | 3,840,336 | USD | 183 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 231,442 | USD | |
| At 2017-03-31 | 228,249 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 162,022 | USD | 92 |
| 2017-04-01 to 2017-09-30 | 220,242 | USD | 183 |
| 2016-07-01 to 2016-09-30 | 6,264 | USD | 92 |
| 2016-04-01 to 2016-09-30 | 111,580 | USD | 183 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 715,400 | USD | 92 |
| 2017-04-01 to 2017-09-30 | 1,401,309 | USD | 183 |
| 2016-07-01 to 2016-09-30 | 813,773 | USD | 92 |
| 2016-04-01 to 2016-09-30 | 1,231,563 | USD | 183 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 53,885,279 | shares | |
| At 2017-03-31 | 48,885,107 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 47,642,526 | USD | |
| At 2017-03-31 | 45,088,171 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 42,149 | USD | |
| At 2017-03-31 | 42,149 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 612,284 | USD | |
| At 2017-03-31 | 595,102 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 416,053 | USD | |
| At 2017-03-31 | 367,681 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 4,860,690 | USD | |
| At 2017-03-31 | 5,030,624 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 1,873,613 | USD | |
| At 2017-03-31 | 1,228,657 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 169,287 | USD | |
| At 2017-03-31 | 228,047 | USD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | -3,615,361 | USD | 92 |
| 2017-04-01 to 2017-09-30 | -5,855,877 | USD | 183 |
| 2016-07-01 to 2016-09-30 | -1,400,560 | USD | 92 |
| 2016-04-01 to 2016-09-30 | -3,332,273 | USD | 183 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 1,505,528 | USD | 92 |
| 2017-04-01 to 2017-09-30 | 2,133,134 | USD | 183 |
| 2016-07-01 to 2016-09-30 | 577,853 | USD | 92 |
| 2016-04-01 to 2016-09-30 | 1,881,467 | USD | 183 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 23,820 | USD | 92 |
| 2017-04-01 to 2017-09-30 | 48,372 | USD | 183 |
| 2016-07-01 to 2016-09-30 | 23,590 | USD | 92 |
| 2016-04-01 to 2016-09-30 | 33,753 | USD | 183 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 76,985 | USD | 92 |
| 2017-04-01 to 2017-09-30 | 169,934 | USD | 183 |
| 2016-04-01 to 2017-03-31 | 550,080 | USD | 365 |
| 2016-07-01 to 2016-09-30 | 0 | USD | 92 |
| 2016-04-01 to 2016-09-30 | 0 | USD | 183 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | -184,075 | USD | 92 |
| 2017-04-01 to 2017-09-30 | -355,224 | USD | 183 |
| 2016-07-01 to 2016-09-30 | 400,499 | USD | 92 |
| 2016-04-01 to 2016-09-30 | 396,483 | USD | 183 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-09-30 | -363,056 | USD | 183 |
| 2016-04-01 to 2016-09-30 | 87,402 | USD | 183 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-09-30 | 3,193 | USD | 183 |
| 2016-04-01 to 2016-09-30 | 191,548 | USD | 183 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-09-30 | 172,634 | USD | 183 |
| 2016-04-01 to 2016-09-30 | -696,874 | USD | 183 |
Inspect the source
- Entity
- BIONIK LABORATORIES CORP. / CIK 0001508381
- Captured
- SEC response SHA-256
5bb7fb15cbaa342375014f08f1afdc44fc44d4a568725cfe6cc78e258108a4c6
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001508381.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))